Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ: IMDX · Real-Time Price · USD

3.840

-0.080 (-2.04%)

At close: Sep 1, 2026, 4:00 PM EDT

3.830

-0.010 (-0.26%)

After-hours: Sep 1, 2026, 5:55 PM EDT

IMDX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.76	11.58	8.64	9.43	19.99	32.95
Short-Term Investments	-	-	-	-	0.43	0.9
Cash & Short-Term Investments	17.76	11.58	8.64	9.43	20.43	33.85
Cash Growth	-26.89%	34.13%	-8.44%	-53.82%	-39.66%	333.00%
Receivables	0.19	1.13	1.61	0.48	2.01	1.44
Inventory	0.21	0.45	0.41	-	-	-
Prepaid Expenses	1.66	1.42	0.82	0.64	0.98	0.9
Restricted Cash	0.73	0.73	-	-	-	-
Other Current Assets	-	-	0.28	0.14	2.12	2.95
Total Current Assets	20.54	15.31	11.76	10.7	25.54	39.14
Property, Plant & Equipment	8.1	9.25	6.32	5.44	10.85	8.37
Goodwill	-	-	-	-	-	18.68
Other Intangible Assets	-	-	14.61	56.6	61.63	61.72
Other Long-Term Assets	0.8	1.2	2.39	2.16	2.07	31.65
Total Assets	29.44	25.76	35.08	74.89	100.09	159.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.87	2.54	1.64	0.95	1.25	1.81
Accrued Expenses	6	7.3	4.11	3.22	5.61	4.91
Current Portion of Long-Term Debt	-	-	-	-	-	1.31
Current Portion of Leases	1.71	1.81	1.3	0.67	0.82	0.82
Other Current Liabilities	0.71	0.43	0.23	2.36	4.43	5.27
Total Current Liabilities	10.29	12.08	7.28	7.19	12.11	14.12
Long-Term Leases	0.92	1.69	2.37	2.2	2.73	3.55
Other Long-Term Liabilities	39.54	43.46	37.71	39.9	45.66	76.68
Total Liabilities	50.74	57.22	47.36	49.3	60.5	94.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	394.95	369.21	338.24	310.3	294.93	252.95
Retained Earnings	-416.31	-400.76	-350.54	-289.88	-260.68	-187.77
Comprehensive Income & Other	0.07	0.09	0.02	0.05	0.04	0.04
Total Common Equity	-21.3	-31.46	-12.27	20.47	34.29	65.22
Shareholders' Equity	-21.3	-31.46	-12.27	25.59	39.59	65.22
Total Liabilities & Equity	29.44	25.76	35.08	74.89	100.09	159.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.63	3.5	3.66	2.87	3.54	5.68
Net Cash (Debt)	15.13	8.09	4.97	6.56	16.88	28.18
Net Cash Growth	-27.65%	62.63%	-24.24%	-61.12%	-40.08%	-
Net Cash Per Share	0.45	0.27	0.38	0.86	3.05	6.34
Filing Date Shares Outstanding	32.72	32.17	28.6	8.27	5.93	4.61
Total Common Shares Outstanding	32.62	28.68	17.45	8.26	5.93	4.61
Working Capital	10.26	3.23	4.48	3.5	13.43	25.02
Book Value Per Share	-0.65	-1.10	-0.70	2.48	5.78	14.14
Tangible Book Value	-21.3	-31.46	-26.88	-36.13	-27.34	-15.19
Tangible Book Value Per Share	-0.65	-1.10	-1.54	-4.37	-4.61	-3.29
Machinery	13.58	12.52	8.37	6.91	9.41	6.29
Construction In Progress	0.26	0.77	0.34	0.73	2.14	1.24

SEC Filings: 10-K · 10-Q